These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7987283)

  • 1. [Gene therapy: facts and hopes].
    Burny MA
    Bull Mem Acad R Med Belg; 1993; 148(11 Pt 2):60-5. PubMed ID: 7987283
    [No Abstract]   [Full Text] [Related]  

  • 2. [It is no more about cancer, but it is already about gene therapy].
    Jeanteur P
    Bull Cancer; 2000 Jun; 87(6):445-6. PubMed ID: 10928794
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene therapy.
    Culver KW
    J Insur Med; 1996; 28(2):121-4. PubMed ID: 10163946
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene therapy progress and prospects: gene therapy for severe combined immunodeficiency.
    Gaspar HB; Howe S; Thrasher AJ
    Gene Ther; 2003 Nov; 10(24):1999-2004. PubMed ID: 14566358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LMO2 and gene therapy for severe combined immunodeficiency.
    Stone BD
    N Engl J Med; 2004 Jun; 350(24):2526-7; author reply 2526-7. PubMed ID: 15195349
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adenosine deaminase deficiency].
    Sakiyama Y
    Ryoikibetsu Shokogun Shirizu; 2000; (32):32-4. PubMed ID: 11212730
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug evaluation: ADA-transduced hematopoietic stem cell therapy for ADA-SCID.
    Taupin P
    IDrugs; 2006 Jun; 9(6):423-30. PubMed ID: 16752313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for inherited immunodeficiencies.
    Howe S; Thrasher AJ
    Curr Hematol Rep; 2003 Jul; 2(4):328-34. PubMed ID: 12901330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost analysis of treatments for severe combined immunodeficiency patients caused by adenosine deaminase deficiency: comparison of gene therapy and bone marrow transplantation.
    Imai H
    Hokkaido Igaku Zasshi; 1998 Mar; 73(2):137-45. PubMed ID: 9612707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human gene therapy.
    Gibaldi M
    Pharmacotherapy; 1993; 13(2):79-87. PubMed ID: 8469625
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene therapy of primary immunodeficiencies.
    Fischer A; De Saint Basile G; Disanto JP; Hacein-Bey S; Sharara L; Cavazzana-Calvo M
    Adv Nephrol Necker Hosp; 1997; 26():107-20. PubMed ID: 8922128
    [No Abstract]   [Full Text] [Related]  

  • 12. [Gene therapy for adenosine deaminase deficiency].
    Sakiyama Y
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):27-32. PubMed ID: 8727372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy of severe combined immunodeficiencies.
    Cavazzana-Calvo M; Hacein-Bey S; Yates F; de Villartay JP; Le Deist F; Fischer A
    J Gene Med; 2001; 3(3):201-6. PubMed ID: 11437325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy of severe combined immunodeficiencies.
    Fischer A; Hacein-Bey S; Cavazzana-Calvo M
    Nat Rev Immunol; 2002 Aug; 2(8):615-21. PubMed ID: 12154380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy in recovery phase.
    Ready T
    Nat Med; 2002 May; 8(5):429-30. PubMed ID: 11984571
    [No Abstract]   [Full Text] [Related]  

  • 16. Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy.
    Hershfield MS
    Semin Hematol; 1998 Oct; 35(4):291-8. PubMed ID: 9801258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Severe combined immunodeficiencies: a case of adenosine-deaminase deficit].
    Macellaro P; Savarino A; Cucchi G; Lazzati A; Zuccotti GV
    Pediatr Med Chir; 2004; 26(3):191-5. PubMed ID: 16366403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future tense for in utero gene therapy.
    Fox JL
    Nat Biotechnol; 1998 Nov; 16(11):1002-3. PubMed ID: 9831019
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo kinetics of transduced cells in peripheral T cell-directed gene therapy: role of CD8+ cells in improved immunological function in an adenosine deaminase (ADA)-SCID patient.
    Kawamura N; Ariga T; Ohtsu M; Kobayashi I; Yamada M; Tame A; Furuta H; Okano M; Egashira M; Niikawa N; Kobayashi K; Sakiyama Y
    J Immunol; 1999 Aug; 163(4):2256-61. PubMed ID: 10438969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adenosine deaminase deficiency].
    Okawa H
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):240-2. PubMed ID: 9833480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.